[HTML][HTML] t4 workshop report: State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology

N Alépée, A Bahinski, M Daneshian, B De Wever… - Altex, 2014 - ncbi.nlm.nih.gov
Integrated approaches using different in vitro methods in combination with bioinformatics
can (i) increase the success rate and speed of drug development;(ii) improve the accuracy of …

[HTML][HTML] 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs

MAG Barbosa, CPR Xavier, RF Pereira, V Petrikaitė… - Cancers, 2021 - mdpi.com
Simple Summary Three-dimensional (3D) cell culture models have been proposed as
alternatives for initial drug screening to increase drug development efficiency. In addition to …

Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read‐outs

VE Santo, SP Rebelo, MF Estrada… - Biotechnology …, 2017 - Wiley Online Library
There is cumulating evidence that in vitro 3D tumor models with increased physiological
relevance can improve the predictive value of pre‐clinical research and ultimately contribute …

3D organ models—Revolution in pharmacological research?

M Weinhart, A Hocke, S Hippenstiel, J Kurreck… - Pharmacological …, 2019 - Elsevier
Abstract 3D organ models have gained increasing attention as novel preclinical test systems
and alternatives to animal testing. Over the years, many excellent in vitro tissue models have …

Could 3D models of cancer enhance drug screening?

V Brancato, JM Oliveira, VM Correlo, RL Reis… - Biomaterials, 2020 - Elsevier
Cancer is a multifaceted pathology, where cellular and acellular players interact to drive
cancer progression and, in the worst-case, metastasis. The current methods to investigate …

Biomimetic 3D tissue models for advanced high-throughput drug screening

KH Nam, AST Smith, S Lone… - Journal of laboratory …, 2015 - journals.sagepub.com
Most current drug screening assays used to identify new drug candidates are 2D cell-based
systems, even though such in vitro assays do not adequately re-create the in vivo complexity …

3D in vitro tissue models and their potential for drug screening

L Kimlin, J Kassis, V Virador - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: The development of one standard, simplified in vitro three-dimensional tissue
model suitable to biological and pathological investigation and drug-discovery may not yet …

Three‐dimensional cell culture models for anticancer drug screening: Worth the effort?

ET Verjans, J Doijen, W Luyten… - Journal of cellular …, 2018 - Wiley Online Library
High attrition of new oncology drug candidates in clinical trials is partially caused by the poor
predictive capacity of artificial monolayer cell culture assays early in drug discovery …

[HTML][HTML] Concerns, challenges and promises of high-content analysis of 3D cellular models

N Carragher, F Piccinini, A Tesei, OJT Jr… - Nature reviews Drug …, 2018 - nature.com
© 2018 Mac millan Publishers Li mited, part of Springer Nature. All rights reserved. deeper
penetration of light into tissue, but many areas require improvement, especially if 3D …

Life in 3D is never flat: 3D models to optimise drug delivery

KA Fitzgerald, M Malhotra, CM Curtin, FJ O'Brien… - Journal of controlled …, 2015 - Elsevier
The development of safe, effective and patient-acceptable drug products is an expensive
and lengthy process and the risk of failure at different stages of the development life-cycle is …